Top Page
Assura plc
(LSE:AGR)
Assura plc (AGR) vs. iShares MSCI United Kingdom ETF (EWC)
Assura plc Business Overview & Revenue Model
Assura plc Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 183.80M | 183.80M | 157.80M | 152.00M | 137.30M | 121.00M |
| Gross Profit | 167.10M | 167.10M | 143.30M | 139.40M | 126.70M | 112.10M |
| EBITDA | 152.75M | 207.60M | -1.30M | -92.20M | 182.30M | 132.40M |
| Net Income | 166.00M | 166.00M | -28.80M | -119.20M | 155.90M | 108.30M |
Balance Sheet | ||||||
| Total Assets | 3.28B | 3.28B | 2.81B | 2.92B | 3.12B | 2.56B |
| Cash, Cash Equivalents and Short-Term Investments | 55.30M | 55.30M | 33.20M | 118.00M | 243.50M | 46.60M |
| Total Debt | 1.54B | 1.54B | 1.25B | 1.25B | 1.25B | 954.20M |
| Total Liabilities | 1.64B | 1.64B | 1.34B | 1.34B | 1.33B | 1.03B |
| Stockholders Equity | 1.64B | 1.64B | 1.47B | 1.59B | 1.79B | 1.53B |
Cash Flow | ||||||
| Free Cash Flow | 130.50M | 91.70M | 99.60M | 78.90M | 91.10M | 76.70M |
| Operating Cash Flow | 110.50M | 110.50M | 102.40M | 94.10M | 94.60M | 77.40M |
| Investing Cash Flow | -284.10M | -284.10M | -97.70M | -130.40M | -293.90M | -267.50M |
| Financing Cash Flow | 196.30M | 196.30M | -87.30M | -89.20M | 396.20M | 218.20M |
Assura plc Technical Analysis
Assura plc Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | 972.06M | 15.79 | 0.00% | 7.85% | 7.57% | 0.00% | |
76 Outperform | 614.06M | 5.60 | 0.00% | 3.85% | 16.81% | 89.02% | |
74 Outperform | 2.29B | 12.26 | 0.00% | 7.91% | 0.96% | 0.00% | |
68 Neutral | £1.52B | 8.86 | 10.66% | 7.08% | 16.01% | ― | |
54 Neutral | 55.95M | -23.70 | -2.63% | 5.63% | -6.44% | 75.18% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
Assura plc Corporate Events
Assura plc announced that Ed Smith, the Chairman, sold his entire holding of 166,649 ordinary shares, while Jenny Smith, a connected person, sold 50,486 shares. These transactions, conducted on 13 August 2025, were disclosed in compliance with the Market Abuse Regulation. The sale of shares by the Chairman and a connected person might impact investor perceptions and could influence the company’s stock performance, given the significant stake involved.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc announced that several of its key executives have exercised their Performance Share Plan (PSP) awards for 2023 and 2024. The shares were vested and subsequently sold to cover income tax and national insurance liabilities, with the remaining shares sold in full. This move aligns with the company’s remuneration strategy and reflects its commitment to transparency and regulatory compliance, as the transactions were conducted in accordance with the Market Abuse Regulation.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a recommended combination with Primary Health Properties PLC (PHP) through a takeover offer, where PHP will acquire all issued and to be issued ordinary shares of Assura. The Assura Board continues to support the Increased PHP Offer as being in the best interests of its shareholders, despite a competing cash offer from Sana Bidco Limited. Assura shareholders are urged to accept the PHP offer by the specified deadline, which could significantly impact the company’s market position and shareholder value.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc announced that several of its key executives, including the CEO and CFO, have acquired partnership shares and were awarded matching shares under the company’s Share Incentive Plan. This move is part of the company’s strategy to align the interests of its management with those of its shareholders, potentially strengthening its market position and enhancing shareholder value.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc announced the exercise of 2022 PSP awards by its PDMRs, resulting in the vesting and sale of shares to cover tax liabilities. The Remuneration Committee allowed the sale of sufficient shares to meet these obligations, with additional shares sold by some executives. This transaction reflects the company’s ongoing commitment to aligning executive incentives with shareholder interests, potentially impacting stakeholder perceptions and market positioning.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura PLC has announced a change in its major holdings, with Schroders Plc adjusting its voting rights in the company. The adjustment saw Schroders Plc’s voting rights decrease from 5.238072% to 4.861668%, as of July 18, 2025. This change in voting rights could potentially impact the company’s shareholder dynamics and influence future decision-making processes.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc reported robust financial results for the year ending March 31, 2025, with a significant increase in investment property value to £3,099 million and a net rental income rise of 17% to £167.1 million. The company’s disciplined investment strategy included the acquisition of 14 independent hospitals and the completion of five development projects. Assura’s ESG strategy emphasizes creating healthy environments and communities, with notable achievements in net zero carbon developments and increased social value generation. The company’s strong financial position and active portfolio management enhance its market positioning, benefiting stakeholders through sustained growth and dividend increases.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced the issuance of 5,784,304 new ordinary shares to its Employee Benefit Trust, as part of its Performance Share Plan. These shares are set to be listed on the London Stock Exchange, increasing the total number of Assura’s ordinary shares in issue to 3,256,393,191. This move is expected to enhance the company’s share liquidity and provide additional voting rights, reflecting Assura’s ongoing commitment to employee incentives and shareholder engagement.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has released employee opinion letters in relation to two offers made for the company: one by Primary Health Properties PLC and another by Sana Bidco Limited. This publication is part of the regulatory requirements under the City Code on Takeovers and Mergers, potentially impacting the company’s future ownership and strategic direction.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc announced an update to its previous notification regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs), specifically correcting the shareholding figures for CEO Jonathan Murphy. The update reflects the acquisition of partnership shares and award of matching shares under the company’s Share Incentive Plan (SIP), as well as shares acquired following a dividend award. This announcement highlights Assura’s ongoing commitment to aligning management interests with shareholder value, potentially enhancing stakeholder confidence in the company’s governance and operational transparency.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a Special Dividend as part of its takeover by Primary Health Properties plc (PHP). This move is part of a revised offer where PHP aims to acquire all issued shares of Assura. The Special Dividend, set at 0.84 pence per share, is contingent on the offer becoming unconditional and receiving necessary approvals. This strategic combination is expected to enhance Assura’s market positioning and provide value to its shareholders, with the dividend serving as an acceleration of the expected quarterly interim dividend.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc announced that several key executives acquired partnership shares and were awarded matching shares under the company’s Share Incentive Plan. This move, which also included the acquisition of shares following a dividend award, reflects the company’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially strengthening its market position and stakeholder confidence.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a change in its voting rights structure due to an acquisition by Sana Bidco Limited, which has increased its voting rights to 5.062071%. This development reflects a strategic shift in the company’s shareholder composition, potentially impacting its governance and decision-making processes.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a change in its voting rights structure following an acquisition by Sana Bidco Limited, a company registered in Jersey. As of June 13, 2025, Sana Bidco Limited holds 4.918617% of the voting rights in Assura plc, marking a significant shift in the company’s ownership dynamics. This development may influence Assura’s strategic decisions and could have implications for its stakeholders, particularly in terms of governance and potential future investments.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a change in the voting rights held by Norges Bank, which has significantly reduced its stake from 3.143510% to 0.024090%. This decrease in voting rights indicates a disposal of shares by Norges Bank, which could impact Assura’s shareholder dynamics and influence within the company. The notification of this change was completed on June 16, 2025, highlighting a shift in the investment strategy of one of its major stakeholders.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura PLC, a UK-based company, has been involved in a significant transaction involving financial instruments. Bank of America Corporation has crossed a threshold in its holdings of Assura PLC’s financial instruments, now holding 3.404128% of the voting rights through various swaps and physical swaps. This acquisition may impact Assura’s market positioning and stakeholder interests.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc, a company involved in the healthcare property sector, is currently evaluating a revised share and cash offer from Primary Health Properties plc (PHP) for its entire issued and to be issued ordinary share capital. The revised terms of the PHP offer include the potential acceleration of Assura’s Q3 dividend without reducing the offer’s value and lowering the acceptance condition to more than 50% of voting rights, aligning it with a competing offer from Sana Bidco Limited. The Assura Board is reviewing the offer with its advisers and will provide its views to shareholders by 27 June 2025, advising them to take no action in the meantime.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a recommended best and final increased cash offer from Sana Bidco Limited, a company indirectly owned by KKR and Stonepeak. The offer values Assura’s share capital at approximately £1,696 million, representing a significant premium over previous valuations. The Assura Board has decided to recommend this offer over a competing offer from Primary Health Properties plc (PHP) due to concerns about financial and execution risks associated with the PHP proposal. The decision is expected to provide Assura shareholders with a higher value realization and less risk.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc announced that several of its key managerial personnel, including the CEO and CFO, have acquired partnership shares and were awarded matching shares under the company’s Share Incentive Plan. This move is part of the company’s ongoing efforts to align the interests of its management with those of its shareholders, potentially enhancing stakeholder confidence and reinforcing its market position.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced updates regarding a cash offer from Sana Bidco Limited, a company indirectly owned by funds advised by Kohlberg Kravis Roberts & Co. L.P. and Stonepeak Partners LP. The offer involves the acquisition of all issued and to be issued ordinary share capital of Assura. Additionally, Primary Health Properties plc (PHP) has made a competing share and cash offer. Assura has adjourned the meetings required to implement the Sana Bidco offer and is conducting due diligence on PHP’s offer. Regulatory clearances from several international authorities have been received for the Sana Bidco offer, and a valuation report for properties in Ireland has been published on Assura’s website.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a change in its major holdings, with Norges Bank increasing its voting rights in the company to 3.143510%. This adjustment in holdings reflects a strategic move by Norges Bank, potentially impacting Assura’s governance and shareholder dynamics, and indicating confidence in the company’s market position and future prospects.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc, a UK-based company, has announced an adjournment of its shareholder meetings concerning a cash offer from Sana Bidco Limited. This decision follows a competing offer from Primary Health Properties plc (PHP), which includes both share and cash components. Assura’s board is currently evaluating the PHP offer and has advised shareholders to refrain from taking any action regarding the existing Bidco offer until further notice.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc has announced a quarterly interim dividend of 0.84 pence per share, payable on 9 July 2025, with a record date of 6 June 2025. This dividend will be distributed entirely as Property Income Distribution, with no scrip dividend alternative, impacting shareholders and reflecting the company’s ongoing commitment to providing cash returns.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Assura plc, a company involved in the healthcare property sector, is currently evaluating a firm offer from Primary Health Properties plc (PHP) for its entire issued and to be issued ordinary share capital. The Board of Assura is consulting with its advisers on the PHP Offer and has advised shareholders to refrain from taking any action until further announcements are made.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.